Drug Shortage Report for NXSTAGE PUREFLOW SOLUTION RFP-207-CAN
| Report ID | 251900 |
| Drug Identification Number | 02443287 |
| Brand name | NXSTAGE PUREFLOW SOLUTION RFP-207-CAN |
| Common or Proper name | Hemodialysis Solution |
| Company Name | NXSTAGE MEDICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE MAGNESIUM CHLORIDE DEXTROSE POTASSIUM CHLORIDE CALCIUM CHLORIDE SODIUM LACTATE |
| Strength(s) | 5.552G 0.102G 1.1G 0.075G 0.221G 8.408G |
| Dosage form(s) | SOLUTION |
| Route of administration | HAEMODIALYSIS DIALYSIS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 5000 mL per bag/ Two (2) bags per shipping carton |
| ATC code | B05ZA |
| ATC description | HEMODIALYTICS AND HEMOFILTRATES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-08-01 |
| Actual start date | |
| Estimated end date | 2025-11-01 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-04-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 350 MERRIMACK STREET LAWRENCE, MASSACHUSETTS UNITED STATES 01843 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-04-30 | French | Compare |
| v4 | 2025-04-30 | English | Compare |
| v3 | 2025-03-04 | French | Compare |
| v2 | 2025-03-04 | English | Compare |
| v1 | 2025-03-04 | English | Compare |
Showing 1 to 5 of 5